Aftobetin

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameAftobetin
Drug Alias NameANCA-11
ClassificationSmall moleculesDiagnostic agent (In vivo)
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsCognitive DysfunctionAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California San DiegoCognoptix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCognoptix Inc
Active IndicationsN/A
Inactive IndicationsCognitive DysfunctionAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A